Concepedia

David Yowe

DY

Statistics

Publications

20

Citations

1.8K

H-Index

17

Active since

1995

Affiliations

Millennium Engineering and Integration (United States)(Current)

Novartis (United States)

Novartis (Switzerland)

The University of Texas Southwestern Medical Center

Novartis (Japan)

David Yowe is an author at Millennium Engineering and Integration (United States) specializing in life sciences, pharmacology, and molecular biology.

Publications per year

1995–2021

20

Publications

20

Mitochondrial decay in hepatocytes from old rats: Membrane potential declines, heterogeneity and oxidants increase

Tory M. Hagen, David Yowe, James C. Bartholomew et al. · Proceedings of the National Academy of Sciences · 1997 · 436 citations

Life Sciences, Cell Biology, Physiology +17

RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors

Xin Xu, Weizhong Zeng, Serguei Popov et al. · Journal of Biological Chemistry · 1999 · 255 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +10

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity

Jun Li, Christine Tumanut, Julie-Ann Gavigan et al. · Biochemical Journal · 2007 · 149 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Identification of 2-{2-[2-(5-Bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1<i>H</i>-imidazole (ML00253764), a Small Molecule Melanocortin 4 Receptor Antagonist That Effectively Reduces Tumor-Induced Weight Loss in a Mouse Model

Tricia J. Vos, Andrei Caracoti, Mingshi Dai et al. · Journal of Medicinal Chemistry · 2004 · 101 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 20